Marwyn Value Investors (LON:MVI - Get Free Report) hit a new 52-week high on Monday . The stock traded as high as GBX 233 ($3.09) and last traded at GBX 107.96 ($1.43), with a volume of 17323 shares traded. The stock had previously closed at GBX 104.86 ($1.39).
Marwyn Value Investors Stock Performance
The firm has a market capitalization of £63.13 million, a PE ratio of 7.97 and a beta of 0.12. The business has a 50-day simple moving average of GBX 105.29 and a 200-day simple moving average of GBX 97.89. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.00 and a quick ratio of 1.00.
Marwyn Value Investors (LON:MVI - Get Free Report) last released its quarterly earnings results on Monday, April 28th. The company reported GBX 9.06 ($0.12) earnings per share for the quarter. Marwyn Value Investors had a return on equity of 7.74% and a net margin of 99.97%.
About Marwyn Value Investors
(
Get Free Report)
Marwyn Value Investors Limited specializes in investments in growth capital, buyout, industry consolidation, and acquisition-led growth strategies in small and mid-cap businesses. The fund also invests in consolidation opportunities in industry sectors that are undergoing structural or regulatory change, and is sector agnostic.
Further Reading
Before you consider Marwyn Value Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marwyn Value Investors wasn't on the list.
While Marwyn Value Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
